Wockhardt Management
Management criteria checks 4/4
Wockhardt's CEO is Murtaza Khorakiwala, appointed in Apr 2009, has a tenure of 15.08 years. total yearly compensation is ₹24.00M, comprised of 96.3% salary and 3.8% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth ₹166.57M. The average tenure of the management team and the board of directors is 12.7 years and 8.6 years respectively.
Key information
Murtaza Khorakiwala
Chief executive officer
₹24.0m
Total compensation
CEO salary percentage | 96.3% |
CEO tenure | 15.1yrs |
CEO ownership | 0.2% |
Management average tenure | 12.7yrs |
Board average tenure | 8.6yrs |
Recent management updates
Recent updates
Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%
Feb 21There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump
Dec 19There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues
Oct 14Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Feb 18Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being
Jul 26Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
May 18Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Jan 26What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?
Dec 01CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -₹5b |
Sep 30 2023 | n/a | n/a | -₹5b |
Jun 30 2023 | n/a | n/a | -₹6b |
Mar 31 2023 | ₹24m | ₹23m | -₹6b |
Dec 31 2022 | n/a | n/a | -₹6b |
Sep 30 2022 | n/a | n/a | -₹5b |
Jun 30 2022 | n/a | n/a | -₹3b |
Mar 31 2022 | ₹24m | ₹17m | -₹2b |
Dec 31 2021 | n/a | n/a | -₹787m |
Sep 30 2021 | n/a | n/a | -₹567m |
Jun 30 2021 | n/a | n/a | -₹867m |
Mar 31 2021 | ₹24m | ₹24m | -₹3b |
Dec 31 2020 | n/a | n/a | -₹2b |
Sep 30 2020 | n/a | n/a | -₹3b |
Jun 30 2020 | n/a | n/a | -₹3b |
Mar 31 2020 | ₹24m | ₹24m | -₹2b |
Dec 31 2019 | n/a | n/a | -₹1b |
Sep 30 2019 | n/a | n/a | -₹2b |
Jun 30 2019 | n/a | n/a | -₹2b |
Mar 31 2019 | ₹24m | ₹24m | -₹3b |
Dec 31 2018 | n/a | n/a | -₹3b |
Sep 30 2018 | n/a | n/a | -₹3b |
Jun 30 2018 | n/a | n/a | -₹3b |
Mar 31 2018 | ₹24m | ₹19m | -₹6b |
Compensation vs Market: Murtaza's total compensation ($USD287.52K) is about average for companies of similar size in the Indian market ($USD383.25K).
Compensation vs Earnings: Murtaza's compensation has been consistent with company performance over the past year.
CEO
Murtaza Khorakiwala (50 yo)
15.1yrs
Tenure
₹24,000,000
Compensation
Dr. Murtaza Habil Khorakiwala serves as the Managing Director of Wockhardt Ltd. since April 2009 and has been its Executive Director since March 31, 2009. Dr. Khorakiwala serves as a Director of Khorakiwal...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairman | 20.3yrs | ₹29.00m | 0.39% ₹ 338.3m | |
MD & Executive Director | 15.1yrs | ₹24.00m | 0.19% ₹ 166.6m | |
Executive Director | no data | ₹24.00m | 0.18% ₹ 159.1m | |
Chief Financial Officer | 1.9yrs | no data | no data | |
Chief Scientific Officer of New Drug Discovery | no data | ₹1.71m | no data | |
Senior Vice President of Legal | no data | no data | no data | |
Chief Human Resource Officer | no data | no data | no data | |
Senior Vice President of Business Development | no data | ₹1.61m | no data | |
Head of Global Regulatory Affairs | 10.3yrs | no data | no data | |
President of Supply Chain | no data | no data | no data | |
Managing Director of Wockhardt UK | no data | no data | no data | |
President of Manufacturing | no data | no data | no data |
12.7yrs
Average Tenure
56yo
Average Age
Experienced Management: WOCKPHARMA's management team is seasoned and experienced (12.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairman | 20.3yrs | ₹29.00m | 0.39% ₹ 338.3m | |
MD & Executive Director | 15.2yrs | ₹24.00m | 0.19% ₹ 166.6m | |
Executive Director | 15.1yrs | ₹24.00m | 0.18% ₹ 159.1m | |
Additional Non-Executive Independent Director | 3.8yrs | ₹1.60m | 0.0065% ₹ 5.7m | |
Non-Executive & Independent Director | 7.5yrs | ₹1.60m | no data | |
Non-Executive Director Non- Independent Director | 6.6yrs | ₹400.00k | no data | |
Non-Executive & Independent Director | 9.7yrs | ₹1.60m | no data | |
Independent Director | less than a year | no data | 0.000070% ₹ 60.8k |
8.6yrs
Average Tenure
65yo
Average Age
Experienced Board: WOCKPHARMA's board of directors are considered experienced (8.6 years average tenure).